论文部分内容阅读
目的:观察复合麻醉在乳腺肿瘤术中的临床疗效。方法:将病例按照ASA分级分层,然后在每一层内进行随机分组、合并,采用固定剂量氯胺酮复合咪达唑仑、丙泊酚及氟芬合剂实施静脉复合麻醉。对比两组的临床疗效。结果:C组患者血压及心率影响最大,A组和B组次之,D组影响最小。A组、B组和C组术中上呼吸道梗阻的发生率、体动率及追加率差异均有统计学意义,且均高于D组(X2=29.809,P=0.000)。术后PACU不良反应C组发生率为15%,高于其他组别(X2=8.257,P=0.007);D组患者苏醒时间最短,术中记忆力最长,比较存在统计学差异(P<0.05)。结论:复合麻醉方案是乳腺良性肿瘤手术中的最佳配伍方案,值得临床推广。
Objective: To observe the clinical efficacy of combined anesthesia in breast tumor surgery. METHODS: The cases were stratified according to the ASA classification and randomly grouped and combined in each layer. Compound intravenous anesthesia was performed using a fixed dose of ketamine in combination with midazolam, propofol, and fluphenazine. Compare the clinical efficacy of the two groups. RESULTS: The blood pressure and heart rate were most affected in group C, followed by group A and group B, and group D had the smallest effect. The incidence, rate of body motion and rate of addition of intraoperative upper airway obstruction in group A, group B, and group C were statistically significantly higher than those in group D (X2=29.809, P=0.000). The incidence of adverse reactions in the PACU after operation was 15% in group C, which was higher than that in other groups (X2=8.257, P=0.007). The shortest recovery time in group D was the longest in memory and there was a statistical difference (P<0.05). ). Conclusion: The compound anesthesia scheme is the best compatibility program for benign breast tumor surgery and is worthy of clinical promotion.